Chiara Marzorati
Biographic Data
| ID | 7758160 |
|---|---|
| NAME | Chiara Marzorati |
| GIVEN NAMES | Chiara |
| FAMILY NAME | Marzorati |
| SIGNATURE | MARZORATI C |
| AFFILIATIONS | European Institute of Oncology |
| ORCID | 0000-0001-7761-2804 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Changes over time in self-efficacy to cope with cancer and well-being in women with breast cancer
OBJECTIVE: This study aimed to examine whether self-efficacy to cope with cancer changes over time in patients with breast cancer and whether these potential changes are similar across patients. It also aimed to examine whether these trajectories are related to patient psychological well-being and overall quality of life. METHODS: = 404) from four countries (i.e. Finland, Israel, Italy, and Portugal) were enrolled in the study few weeks after bre…
Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors
ClinicalTrials.gov Identifier: NCT05947903, 2023-06-28
The mutual determination of self-efficacy to cope with cancer and cancer-related coping over time
OBJECTIVE: The aim of this study was to examine the longitudinal impact of self-efficacy to cope with cancer on the cancer-related coping reactions of breast cancer patients and vice versa. DESIGN AND MAIN OUTCOMES MEASURES: = 403) were enrolled in the study a few weeks after surgery or biopsy. Coping self-efficacy was assessed at baseline and six months later (M6). Cancer-related coping was assessed three (M3) and nine months (M9) after baseline…
No prominent works on this page.
The mutual determination of self-efficacy to cope with cancer and cancer-related coping over time
OBJECTIVE: The aim of this study was to examine the longitudinal impact of self-efficacy to cope with cancer on the cancer-related coping reactions of breast cancer patients and vice versa. DESIGN AND MAIN OUTCOMES MEASURES: = 403) were enrolled in the study a few weeks after surgery or biopsy. Coping self-efficacy was assessed at baseline and six months later (M6). Cancer-related coping was assessed three (M3) and nine months (M9) after baseline…
Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors
ClinicalTrials.gov Identifier: NCT05947903, 2023-06-28
Changes over time in self-efficacy to cope with cancer and well-being in women with breast cancer
OBJECTIVE: This study aimed to examine whether self-efficacy to cope with cancer changes over time in patients with breast cancer and whether these potential changes are similar across patients. It also aimed to examine whether these trajectories are related to patient psychological well-being and overall quality of life. METHODS: = 404) from four countries (i.e. Finland, Israel, Italy, and Portugal) were enrolled in the study few weeks after bre…
Cancer survivorship and care (3 works) · Clinical Psychology (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Breast cancer (2 works) · Cancer (2 works) · Cancer-related cognitive impairment studies (2 works) · Psychology (2 works) · Psychotherapist (2 works) · Self-efficacy (2 works)